Bavarian Nordic A/S (BVNRY)
11.78
+0.30
(+2.61%)
USD |
OTCM |
Oct 09, 16:00
Bavarian Nordic Cash from Investing (Quarterly) : -5.386M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.386M |
| March 31, 2026 | -6.158M |
| December 31, 2025 | -139.83M |
| September 30, 2025 | -79.86M |
| June 30, 2025 | -104.85M |
| March 31, 2025 | -52.65M |
| December 31, 2024 | -48.30M |
| September 30, 2024 | 21.07M |
| June 30, 2024 | -93.44M |
| March 31, 2024 | -152.12M |
| December 31, 2023 | -19.16M |
| September 30, 2023 | -15.05M |
| June 30, 2023 | -149.79M |
| March 31, 2023 | 47.70M |
| December 31, 2022 | -81.41M |
| September 30, 2022 | 30.16M |
| June 30, 2022 | -27.91M |
| March 31, 2022 | -43.86M |
| December 31, 2021 | -239.45M |
| September 30, 2021 | -27.28M |
| June 30, 2021 | -17.80M |
| March 31, 2021 | -173.20M |
| December 31, 2020 | 16.93M |
| September 30, 2020 | -21.62M |
| June 30, 2020 | -194.07M |
| Date | Value |
|---|---|
| March 31, 2020 | -92.91M |
| December 31, 2019 | -174.73M |
| September 30, 2019 | 3.230M |
| June 30, 2019 | 20.69M |
| March 31, 2019 | 29.40M |
| December 31, 2018 | -13.02M |
| September 30, 2018 | 30.32M |
| June 30, 2018 | -9.742M |
| March 31, 2018 | -4.858M |
| December 31, 2017 | -63.77M |
| September 30, 2017 | -4.288M |
| June 30, 2017 | -133.73M |
| March 31, 2017 | -2.191M |
| December 31, 2016 | -4.203M |
| September 30, 2016 | -2.697M |
| June 30, 2016 | -41.92M |
| March 31, 2016 | -17.77M |
| December 31, 2015 | 9.495M |
| September 30, 2015 | -1.430M |
| June 30, 2015 | -32.37M |
| March 31, 2015 | -2.173M |
| December 31, 2014 | -91.99M |
| September 30, 2014 | 13.49M |
| June 30, 2014 | -4.209M |
| March 31, 2014 | -6.922M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Evaxion AS | -- |
| Genmab A/S | 2.026M |
| Ascendis Pharma A/S | -3.268M |
| Zealand Pharma A/S | 34.81M |
| Agenus, Inc. | 0.267M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 55.02M |
| Cash from Financing (Quarterly) | -36.42M |
| Free Cash Flow | 168.82M |
| Free Cash Flow Per Share (Quarterly) | 0.2061 |
| Free Cash Flow to Equity (Quarterly) | 48.36M |
| Free Cash Flow to Firm (Quarterly) | 47.77M |
| Free Cash Flow Yield | 6.17% |